Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Scotland Adopts Respiratory Infection Control Guidance Informed by Aerosol Research

By HospiMedica International staff writers
Posted on 16 Sep 2026

Preventing respiratory infection transmission in hospitals remains a core patient and staff safety priority. More...

Many precautions have hinged on the assumption that certain clinical interventions create high-risk aerosols, driving extensive personal protective equipment use and workflow disruption. Health systems need guidance that reflects how aerosols actually arise in care environments. In response, Scotland has adopted a risk-based infection control approach informed by new evidence from the AERATOR study and associated aerosol measurements.

The AERATOR (AERosolisation And Transmission Of SARS-CoV-2 in Healthcare Settings) study took place during the COVID-19 pandemic. It was led by anesthetic, intensive care, infectious disease, and respiratory clinicians at Southmead Hospital and aerosol scientists at the University of Bristol, with support from the National Institute for Health and Care Research Biomedical Research Centre: Bristol. The study also involved Bristol NHS Foundation Trust and examined whether procedures long labeled aerosol-generating truly produce substantial aerosols.

Investigators used PLUME (Portable Low-background Unit for Measuring Exhaled Aerosol) to quantify aerosol production in real time. Measurements were performed in ultraclean operating rooms typically used for orthopedic and neurosurgical procedures, allowing direct characterization of aerosols in clinical environments. The findings identified respiratory aerosols produced during breathing, speech, and coughing as the main route for transmission of infections such as COVID-19.

The study found that most procedures previously considered high risk generated fewer aerosols than coughing or talking. These results challenge procedure-based risk categorization and shift attention toward patient behaviors that drive higher aerosol emission. The findings underpin guidance that emphasizes infection type, patient symptoms, and exposure context.

Scotland is the first country to use this evidence to reshape guidance on limiting respiratory disease spread in health care settings. Public Services Delivery Scotland has issued updated transmission-based precautions that introduce a consistent, risk-based approach across National Health Service Boards, care homes, and wider settings.

The guidance moves away from procedure-focused assessments, ends use of the term “aerosol-generating procedure” in risk evaluations, and will change how personal protective equipment is deployed. Wales has adopted the same approach, while England has not yet fully retired its aerosol-generating procedures list.

"The AERATOR study challenged long-held assumptions about which medical procedures generate aerosols and therefore potentially increase the risk of infection transmission. By using innovative technology to measure aerosols directly in health care settings, we were able to show that many procedures previously considered high risk actually produce fewer aerosols than normal breathing, coughing or talking," said Dr. Andy Shrimpton, academic clinical lecturer in anesthetics at the University of Bristol, who conducted many of the studies during his Ph.D.

“It is extremely unusual to see this evidence so rapidly shape national guidance. Scotland's adoption of a risk-based approach reflects a growing understanding that infection prevention measures should be proportionate to the actual risk. This will help ensure that patients continue to receive safe, effective care while supporting health care staff to make evidence-based decisions about the precautions they use,” said Tony Pickering, professor of neuroscience and anesthesia at the University of Bristol and consultant anesthetist at Bristol NHS Foundation Trust.

Related Links
University of Bristol


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Illustration of capsule magnet system: A) the setup for the external magnetic robotic arms; B) a conceptual illustration of the capsule being magnetically controlled in the human gastrointestinal tract; C) the position of the magnets within the capsule; and D) the motion of the brush during sampling. (Image Credit: Y. Dai et al., 2026/ Device)

Magnetically Guided Capsule Enables Targeted Small Intestine Microbiome Sampling

The small intestinal microbiome is difficult to study because much of the small intestine is long, narrow, and beyond the reach of routine endoscopic tools. Upper endoscopy accesses only the beginning... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.